Abstract
In June 2022, the World Trade Organization adopted a decision at its 12th Ministerial Conference, that could potentially help facilitate easier production of COVID-19 vaccines. This was the outcome of a 20-month long discussion at the WTO on the so-called TRIPS Waiver. But ultimately what resulted was a rather narrow legal mechanism, essentially clarifying existing rules in the WTO TRIPS Agreement.
Original language | English |
---|---|
No. | Online |
Specialist publication | Geneva Health Files |
Publication status | Published - 2022 |